Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2011 Nov 14:8:518.
doi: 10.1186/1743-422X-8-518.

Successful treatment of activated occult hepatitis B in a non-responder chronic hepatitis C patient

Mohamed H Emara  1 , Mohamed I Radwan
Affiliations
Case Reports

Successful treatment of activated occult hepatitis B in a non-responder chronic hepatitis C patient

Mohamed H Emara et al. Virol J. .

Abstract

We reported a 23 years old male with chronic hepatitis C virus infection, discontinued from pegylated interferon/ribavirin combination therapy due to a lack of early virological response. He has developed activation of occult hepatitis B virus that was successfully treated by a one year of lamivudine therapy.

PubMed Disclaimer

References

    1. Brechot C, Thiers V, Kremsdorf D, Nalpas B, Pol S, Paterlini-Brechot P. Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "occult"? Hepatology. 2001;34:194–203. - PubMed
    1. Kannangai R, Vivekanandan P, Netski D, Mehta S, Kirk G, Thomas D, Torbenson M. Liver enzyme flares and occult hepatitis B in persons with chronic hepatitis C infection. J Clinical Virol. 2007;39:101–105. doi: 10.1016/j.jcv.2007.03.006. - DOI - PubMed
    1. Cacciola I, Pollicino T, Squadrito G, Cerenzia G, Orlando M, Raimondo G. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. N Engl J Med. 1999;341:22–6. doi: 10.1056/NEJM199907013410104. - DOI - PubMed
    1. Fukuda R, Ishimura N, Hamamoto S, Moritani M, Uchida Y, Ishihara S, Akagi S, Watanabe M, Kinoshita Y. Co-infection by serologically silent hepatitis B virus may contribute to poor interferon response in patients with chronic hepatitis C by down-regulation of type-I interferon receptor gene expression in the liver. J Med Virol. 2001;63:220–227. doi: 10.1002/1096-9071(200103)63:3<220::AID-JMV1004>3.0.CO;2-3. - DOI - PubMed
    1. Nirei K, Kaneko M, Moriyama M, Arakawa Y. The clinical features of chronic hepatitis C are not affected by the coexistence of hepatitis B virus DNA in patients negative for hepatitis B surface antigen. Intervirology. 2000;43:95–101. doi: 10.1159/000025030. - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources